The Effects of Bone Marrow Transplantation on X‐linked Hypophosphatemic Mice

The genes responsible for X‐linked hypophosphatemic (XLH) vitamin D‐resistant rickets and the murine homolog, hypophosphatemic mice (Hyp), were identified as PHEX and Phex (phosphate‐regulating gene with homology to endopeptidases on the X chromosome), respectively. However, the mechanism by which inactivating mutations of PHEX cause XLH remains unknown. We investigated the mechanisms by syngeneic bone marrow transplantation (BMT) from wild mice to Hyp mice. The expression of the Phex gene was detected in mouse BM cells. BMT introduced a chimerism in recipient Hyp mice and a significant increase in the serum phosphorus level. The renal sodium phosphate cotransporter gene expression was significantly increased. The effect of BMT on the serum phosphorus level depended on engraftment efficiencies, which represent the dosage of normal gene. Similarly, the serum alkaline phosphatase (ALP) activity was decreased and bone mineral density was increased. Furthermore, the renal expression of 25‐hydroxyvitamin D3 24‐hydroxylase, which is a key enzyme in the catabolic pathway and is increased in XLH/Hyp, was improved. From these results, we conclude that transplantation of normal BM cells improved abnormal bone mineral metabolism and deranged vitamin D metabolism in Hyp by replacing defective gene product(s) with normal gene product(s). This result may provide strong evidence for clinical application of BMT in metabolic bone disorders.

[1]  R. Thomas,et al.  Coordinated Maturational Regulation of PHEX and Renal Phosphate Transport Inhibitory Activity: Evidence for the Pathophysiological Role of PHEX in X‐Linked Hypophosphatemia , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  L. Du,et al.  Evidence for Phex haploinsufficiency in murine X-linked hypophosphatemia , 1999, Mammalian Genome.

[3]  Darwin J. Prockop,et al.  Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta , 1999, Nature Medicine.

[4]  K. Miyazono,et al.  Changes in osteoblast phenotype during differentiation of enzymatically isolated rat calvaria cells. , 1998, Bone.

[5]  M. Marcinkiewicz,et al.  Pex mRNA Is Localized in Developing Mouse Osteoblasts and Odontoblasts , 1998, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[6]  N. El-Badri,et al.  Osteoblasts promote engraftment of allogeneic hematopoietic stem cells. , 1998, Experimental hematology.

[7]  K. H. Albrecht,et al.  DNA sequence analysis of Sry alleles (subgenus Mus) implicates misregulation as the cause of C57BL/6J-Y(POS) sex reversal and defines the SRY functional unit. , 1997, Genetics.

[8]  E. Takeda,et al.  Relative contributions of Na+-dependent phosphate co-transporters to phosphate transport in mouse kidney: RNase H-mediated hybrid depletion analysis. , 1997, Biochemical Journal.

[9]  P. Rowe,et al.  The PEX gene: its role in X-linked rickets, osteomalacia, and bone mineral metabolism. , 1997, Experimental nephrology.

[10]  G. Szot,et al.  Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning , 1997, Nature Medicine.

[11]  D. Prockop.  Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues , 1997, Science.

[12]  T. Meitinger,et al.  Distribution of mutations in the PEX gene in families with X-linked hypophosphataemic rickets (HYP). , 1997, Human molecular genetics.

[13]  C. Goodyer,et al.  Pex/PEX tissue distribution and evidence for a deletion in the 3' region of the Pex gene in X-linked hypophosphatemic mice. , 1997, The Journal of clinical investigation.

[14]  T. Meitinger,et al.  Pex gene deletions in Gy and Hyp mice provide mouse models for X-linked hypophosphatemia. , 1997, Human molecular genetics.

[15]  E. Berger,et al.  Osteogenic growth peptide increases blood and bone marrow cellularity and enhances engraftment of bone marrow transplants in mice. , 1996, Blood.

[16]  F. Glorieux,et al.  cDNA cloning of the murine Pex gene implicated in X-linked hypophosphatemia and evidence for expression in bone. , 1996, Genomics.

[17]  H. Hilfiker,et al.  Structure of murine and human renal type II Na+-phosphate cotransporter genes (Npt2 and NPT2). , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[18]  S. Roy,et al.  Transcriptional regulation and renal localization of 1,25-dihydroxyvitamin D3-24-hydroxylase gene expression: effects of the Hyp mutation and 1,25-dihydroxyvitamin D3. , 1996, Endocrinology.

[19]  O. Bagasra,et al.  Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[20]  A. Poustka,et al.  A gene (PEX) with homologies to endopeptidases is mutated in patients with X–linked hypophosphatemic rickets , 1995, Nature Genetics.

[21]  Toshitaka Nakamura,et al.  Bone‐forming ability of 24r,25‐dihydroxyvitamin d3 in the hypophosphatemic mouse , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[22]  J. Aubin,et al.  Cellular expression of bone‐related proteins during in vitro osteogenesis in rat bone marrow stromal cell cultures , 1994, Journal of cellular physiology.

[23]  C. Scriver,et al.  Parental origin of mutant allele does not explain absence of gene dose in X-linked Hyp mice. , 1993, Genetical research.

[24]  F. Glorieux,et al.  A prospective trial of phosphate and 1,25-dihydroxyvitamin D3 therapy in symptomatic adults with X-linked hypophosphatemic rickets. , 1992, The Journal of clinical endocrinology and metabolism.

[25]  F. Schranck,et al.  X‐linked hypophosphatemic rickets: A study (with literature review) of linear growth response to calcitriol and phosphate therapy , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[26]  Y. Toyoda,et al.  Nucleotide sequence of mouse Sry gene is different between Y chromosome originating from Mus musculus musculus and Mus musculus domesticus. , 1992, Genomics.

[27]  C. Scriver,et al.  X-linked hypophosphatemia. A phenotype in search of a cause. , 1992, The International journal of biochemistry.

[28]  F. Glorieux,et al.  Defective bone formation by hyp mouse bone cells transplanted into normal mice: Evidence in favor of an intrinsic osteoblast defect , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[29]  J. Simpson,et al.  Effects of therapy in X-linked hypophosphatemic rickets. , 1991, The New England journal of medicine.

[30]  G. Semenza,et al.  Cloning and expression of cDNA for a Na/Pi cotransport system of kidney cortex. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[31]  A. Bettinelli,et al.  Acute effects of calcitriol and phosphate salts on mineral metabolism in children with hypophosphatemic rickets. , 1991, The Journal of pediatrics.

[32]  H. Tenenhouse,et al.  Abnormal regulation of renal vitamin D catabolism by dietary phosphate in murine X-linked hypophosphatemic rickets. , 1990, The Journal of clinical investigation.

[33]  H. Tenenhouse,et al.  Increased renal catabolism of 1,25-dihydroxyvitamin D3 in murine X-linked hypophosphatemic rickets. , 1988, The Journal of clinical investigation.

[34]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[35]  A. Doucet,et al.  Renal sodium transport in vitamin D resistant hypophosphatemic rickets. , 1985, Canadian journal of physiology and pharmacology.

[36]  F. Glorieux,et al.  Osteoblasts isolated from mouse calvaria initiate matrix mineralization in culture , 1983, The Journal of cell biology.

[37]  C. Scriver,et al.  Effect of 1,25-dihydroxyvitamin D3 on phosphate homeostasis in the X-linked hypophosphatemic (Hyp) mouse. , 1981, Endocrinology.

[38]  R. Gray,et al.  Abnormal vitamin D metabolism in the X-linked hypophosphatemic mouse. , 1980, Endocrinology.

[39]  R. Mcinnes,et al.  Renal handling of phosphate in vivo and in vitro by the X-linked hypophosphatemic male mouse: evidence for a defect in the brush border membrane. , 1978, Kidney international.

[40]  F. Glorieux,et al.  Hypophosphatemia: mouse model for human familial hypophosphatemic (vitamin D-resistant) rickets. , 1976, Proceedings of the National Academy of Sciences of the United States of America.